REG - GSK PLC - Q2 2026 Results Date Confirmed - 28 July 2026

GSKAnnouncement

Yesterday 10:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260522:nRSV4758Fa&default-theme=true

RNS Number : 4758F  GSK PLC  22 May 2026

GSK plc

 

GSK confirms that the Company's Q2 2026 results are due to be published via
the London Stock Exchange on Tuesday 28 July 2026. GSK will also provide an
update on portfolio growth opportunities.

 

The results announcement dates and respective record and dividend dates for
the remainder of the financial year are set out below:

 

 Results  Announcement date           Ordinary Shares Ex-dividend date  American Depositary Shares Ex-dividend date  Record date              Last date for DRIP elections  Payable
 Q2 2026  Tuesday 28 July 2026        Thursday 13 August 2026                                                        Friday 14 August 2026    Thursday 17 September 2026    Thursday 8 October 2026

                                                                        Friday 14 August 2026

 Q3 2026                              Thursday 12 November 2026         Friday 13 November 2026                      Friday 13 November 2026  Monday 14 December 2026       Thursday 7 January 2027

          Wednesday 28 October 2026

 Q4 2026                              Thursday 18 February 2027         Friday 19 February 2027                      Friday 19 February 2027  Tuesday 16 March 2027         Thursday 8 April 2027

          Wednesday 3 February 2027

 

These dates are indicative and may be subject to change.

 

 

V A Whyte

Company Secretary

 

22 May 2026

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCAKBBDCBKKPPB



            Copyright 2019 Regulatory News Service, all rights reserved